Gregory W Matz insider trades
Open-market stock purchases and sales by Gregory W Matz, Director at Dare Bioscience, Inc, from SEC Form 4 filings since Jan 9, 2012.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +210%.